• Customer Login
  • Search
KindredBio
  • About
    • Background
    • KindredBio Leadership
    • Board of Directors
  • Pipeline
    • Feline Pipeline
    • Canine Pipeline
    • Clinical Trials
  • Products
    • Zimeta™ (dipyrone injection)
  • Technology
    • Veterinary Recombinant Biologics
    • Manufacturing Process
  • Education
    • Continuing Education
    • KINections
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Stock Information
    • Financial Information
    • Investor Resources
  • News
    • Press Releases
  • Contact Us
    • Contact Us
    • Careers
  • Menu

login

You are here: Home / login
Username
Password

» Lost your Password?

News

  • Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine CandidatesOctober 7, 2020 - 8:08 am
  • Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal AntibodySeptember 16, 2020 - 8:08 am
  • Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth ConferenceSeptember 9, 2020 - 8:06 am

Events

  • Event: Kindred Biosciences to Present at Cantor Global Healthcare ConferenceSeptember 9, 2020 - 8:12 am
  • Event: Kindred Biosciences to Present at H.C. Wainwright Global Investment ConferenceSeptember 9, 2020 - 8:09 am
  • Event: Kindred Biosciences to Present at LD Micro 500August 31, 2020 - 2:59 pm
$4.43 Stock is Down -0.02 (-0.45%)
KIN (Common Stock)
Previous Close Volume
$4.45 45,959
Intraday High Intraday Low
$4.49 $4.34
52 Week High 52 Week Low
$11.93 $3.10
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top